STEPHEN PAPPAS

TitleAdjunct Associate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address7200 CAMBRIDGE
Houston, 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wong F, Pappas SC. Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis. Intensive Care Med. 2024 Oct 23. PMID: 39441357.
      Citations:    Fields:    
    2. Weinberg EM, Wong F, Vargas HE, Curry MP, Jamil K, Pappas SC, Sharma P, Reddy KR. Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin. Liver Transpl. 2024 04 01; 30(4):347-355. PMID: 37801553.
      Citations:    
    3. Sigal SH, Pappas SC, Jamil K. Reply. Clin Gastroenterol Hepatol. 2023 11; 21(12):3198-3199. PMID: 37217157.
      Citations:    
    4. Velez JCQ, Wong F, Reddy KR, Sanyal AJ, Vargas HE, Curry MP, Gonzalez SA, Pappas SC, Jamil K. The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome. Kidney360. 2023 08 01; 4(8):1030-1038. PMID: 37143199; PMCID: PMC10482068.
      Citations:    
    5. Sigal SH, Sanyal AJ, Frederick RT, Weinberg EM, Pappas SC, Jamil K. Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3455-3457.e3. PMID: 36848979.
      Citations:    
    6. Wong F, Pappas SC, Reddy KR, Vargas H, Curry MP, Sanyal A, Jamil K. Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther. 2022 10; 56(8):1284-1293. PMID: 35995728; PMCID: PMC9804971.
      Citations:    
    7. Pappas SC. Hepatitis B and Health Care Workers. Clin Liver Dis. 2021 11; 25(4):859-874. PMID: 34593158.
      Citations:    Fields:    Translation:HumansCells
    8. Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K, CONFIRM Study Investigators. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. N Engl J Med. 2021 03 04; 384(9):818-828. PMID: 33657294.
      Citations:    
    9. Wong F, Boyer TD, Sanyal AJ, Pappas SC, Escalante S, Jamil K. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome. Nephrol Dial Transplant. 2020 09 01; 35(9):1554-1561. PMID: 30887050; PMCID: PMC7473801.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    10. Balakrishnan M, Pappas SC. Alcohol and the Law. Clin Liver Dis. 2019 02; 23(1):25-38. PMID: 30454830.
      Citations: 1     Fields:    Translation:Humans
    11. Mindikoglu AL, Pappas SC. Predictors of Response to Terlipressin in Hepatorenal Syndrome. Clin Gastroenterol Hepatol. 2018 07; 16(7):1174. PMID: 29551736; PMCID: PMC6008198.
      Citations: 1     Fields:    Translation:Humans
    12. Tau JA, Pappas SC. Editorial: hepatitis C virus (HCV) disease progression - HCV cure and the elimination of the "ethnic slope". Aliment Pharmacol Ther. 2017 11; 46(10):1011-1012. PMID: 29052862.
      Citations:    
    13. Mindikoglu AL, Pappas SC. New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol. 2018 02; 16(2):162-177.e1. PMID: 28602971; PMCID: PMC5831376.
      Citations: 16     Fields:    Translation:Humans
    14. Sanyal AJ, Boyer TD, Frederick RT, Wong F, Rossaro L, Araya V, Vargas HE, Reddy KR, Pappas SC, Teuber P, Escalante S, Jamil K. Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies. Aliment Pharmacol Ther. 2017 06; 45(11):1390-1402. PMID: 28370090; PMCID: PMC5434950.
      Citations:    
    15. Wong F, Pappas SC, Boyer TD, Sanyal AJ, Bajaj JS, Escalante S, Jamil K, REVERSE Investigators. Terlipressin Improves Renal Function and Reverses Hepatorenal?Syndrome in Patients With Systemic Inflammatory?Response?Syndrome. Clin Gastroenterol Hepatol. 2017 02; 15(2):266-272.e1. PMID: 27464593.
      Citations: 13     Fields:    Translation:Humans
    16. Boyer TD, Sanyal AJ, Wong F, Frederick RT, Lake JR, O'Leary JG, Ganger D, Jamil K, Pappas SC, REVERSE Study Investigators. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. Gastroenterology. 2016 Jun; 150(7):1579-1589.e2. PMID: 26896734.
      Citations: 57     Fields:    Translation:HumansCTClinical Trials
    17. Lin M, Pappas SC, Sellin J, El-Serag HB. Curbside Consultations: The Good, the Bad, and the Ugly. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):2-4. PMID: 26698231.
      Citations: 1     Fields:    Translation:Humans
    PAPPAS's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (64)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _